These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18154757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. European Glaucoma Prevention Study.
    Quigley HA.
    Ophthalmology; 2005 Sep; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systemic antihypertensive medication and incident open-angle glaucoma.
    Müskens RP, de Voogd S, Wolfs RC, Witteman JC, Hofman A, de Jong PT, Stricker BH, Jansonius NM.
    Ophthalmology; 2007 Dec; 114(12):2221-6. PubMed ID: 17568677
    [Abstract] [Full Text] [Related]

  • 7. [The role of Cosopt in glaucoma treatment].
    Călugăru D, Călugăru M.
    Oftalmologia; 2008 Dec; 52(4):15-25. PubMed ID: 19354158
    [Abstract] [Full Text] [Related]

  • 8. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A, Sánchez M.
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Neuroprotection and vasoprotection in glaucoma].
    Ignat F.
    Oftalmologia; 2004 Jun; 48(2):5-14. PubMed ID: 15341092
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
    Konstas AG, Kozobolis VP, Tsironi S, Makridaki I, Efremova R, Stewart WC.
    Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of ocular hypertension: Hamlet's Lament revisited.
    Sommer A.
    Arch Ophthalmol; 2010 Mar; 128(3):363-4. PubMed ID: 20212209
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
    Lupinacci AP, Netland PA, Fung KH, Evans D, Zhao Y.
    Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.